Fact CheckerSign in

NCT07849595Not yet recruiting

Monitoring Blood Pressure at Home and Pharmacy Telehealth Among People Living With HIV

REmote Blood Pressure Monitoring and Pharmacist-Led Telehealth Program in an Emergency Department Transitional Care Clinic

Source: ClinicalTrials.gov · Last updated 30 Sept 2026

Brief summary (registry, in English)

The overall goal of this project is to determine if measuring blood pressure at home and staying in contact with a team of pharmacists and physicians to manage participants' blood pressure is useful. The study will enroll 552 participants who are seen at the University of Alabama at Birmingham 1917 Dewberry Clinic and Vanderbilt Comprehensive Care Center. Half of the participants (276 patients) will be asked to measure blood pressure at home, and half of the participants (276 patients) will continue to receive usual care. Participants who measure blood pressure at home will also meet with a pharmacist weekly over the phone to discuss blood pressure readings and have blood pressure medications prescribed if needed. This program will last 6 months.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
572 (estimated)
First submitted
24 Sept 2026
Start date
1 Feb 2027
Primary completion date
1 Feb 2031
Lead sponsor
University of Alabama at Birmingham
NCT number
NCT07849595

What you commit to

  • Study type: Interventional
  • Planned participants: 572
  • From 1 Feb 2027 to the primary completion date, 1 Feb 2031
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Systolic BP ≥ 160 mmHg or Diastolic BP ≥ 100 mmHg (i.e. severe range hypertension (HTN) by the 2025 American College of Cardiology/American Heart Association BP guidelines) as they typically are referred to immediate treatment intensification. Since the prevalence of severe HTN is low (i.e.\<5%) in the US population, exclusion of these individuals will have only a small effect on the study.)
  • History of known major arrhythmias

Other

  • Lack of willingness or inability to provide written informed consent
  • Individuals who work overnight or second shift
  • Currently pregnant or breastfeeding
  • Arm circumference \>50 cm. \*The upper limit for the largest BP cuff for oscillometric BP devices is typically 50-52 cm; data from the National Health and Nutrition Examination Survey, 2011-2016 indicated that \<1% of US adults have an arm circumference \>50 cm, so this will have minimal effect on our study

Who the study is looking for

  • Age ≥18 years
  • Ability to speak English
  • Seen at UAB's 1917 Dewberry Clinic or Vanderbilt's Comprehensive Care Clinic
  • Blood pressure at Clinic: Systolic BP ≥ 130 mmHg or Diastolic BP ≥ 80 mmHg
  • Have a cellphone with video capability

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.